Interpretation of plasma protein measurements in end-stage renal disease

Blood Purification

Volumn 18, Issue 4, 2000, Pages 337-342

  Kaysen, George A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; IRON; PLASMA PROTEIN; PREALBUMIN; TRANSFERRIN;

ACUTE PHASE RESPONSE; CONFERENCE PAPER; HEMODIALYSIS; HYPOALBUMINEMIA; INFLAMMATION; IRON DEFICIENCY; KIDNEY FAILURE; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MALNUTRITION;

EID: 0033807515     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014459     Document Type: Conference Paper

References (81)

1. United States Renal Data System 1995: Annual Data Report. Am J Kidney Dis 1995;26.
2. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
3. Owen WFJ, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis (see comments). N Engl J Med 1993;329:1001-1006.
4. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
5. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 1999; in press.
6. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;217:107-114.
7. Kirsch R, Frith L, Black E, Hoffenberg R: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 1968;217: 578-579.
8. Pain VM, Clemens MJ, Garlick PJ: The effect of dietary protein deficiency on albumin synthesis and on the concentration of active albumin messenger ribonucleic acid in rat liver. Biochem J 1978;172:129-135.
9. Kaysen GA, Jones H Jr, Hutchison FN: High protein diets stimulate albumin synthesis in nephrotic rats at the site of albumin mRNA transcription. Kidney Int 1989;27:SI68-S172.
10. Kaysen GA, Jones H Jr, Martin V, Hutchison FN: A low protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 1989;83: 1623-1629.
11. Yap SH, Strair RK, Shafritz DA: Effect of a short-term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver. J Biol Chem 1978;253:4944-4950.
12. Yap SH, Strair RK, Shafritz DA: Identification of albumin mRNP's in the cytosol of fasting rat liver and influence of tryptophan or a mixture of amino acids. Biochcm Biophys Res Commun 1978;83:427-433.
13. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Sehen GH, Gandi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33:1567-1585.
14. Schoenfeld PY, Henry RR, Laird NM, Roxe DM: Assessment of nutritional status of the national cooperative dialysis study population. Kidney Int 1983;23(suppl 13):80-88.
15. Acchiardo SR, Moore LW, Latour AP: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983;24(suppl 16): S-199-S-203.
16. Morlese JF, Forrester T, Del Rosario M, Frazer M, Jahoor F: Transferrin kinetics are altered in children with severe protein-energy malnutrition. J Nutr 1997;127:1469-1474.
17. Jones M, Hagen T, Boyle CA. Vonesh E, Hamburger R, Charytan C, Sandroni S, Bernard D, Piraino B, Schreiber M, Gehr T, Fein P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraus A Jr, McDonald L, Hartnett M, Weaver M, Martis L, Moran J: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis 1998;32:761-769.
18. Kopple JD, Levey AS, Greene T, Chumlea WC, Gassman JJ, Hollinger DL, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS: Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 52:778-791.
19. McKnight GS, Lee DC, Hemmaplardh D, Finch CA, Palmiter RD: Transferrin gene expression: Effects of nutritional iron deficiency. J Biol Chem 1980;255:144-147.
20. Cox LA, Adrian GS: Posttranscriptional regulation of chimeric human transferrin genes by iron. Biochemistry 1993;32:4738-4745.
21. Simpson RJ: Effect of hypoxic exposure on iron absorption in heterozygous hypotransferrinaemic mice. Ann Hematol 1992;65:260-264.
22. Colehour JK, Borsook H, Graybiel A: Effect of hypoxia on serum iron and the unsaturated iron-binding capacity of serum in rats. Am J Physiol 1957;191:113-114.
23. Osterloh KRS, Simpson RJ, Snape S, Peters TJ: Intestinal iron absorption and mucosal transferrin in rats subjected to hypoxia. Blut 1987;55:421-431.
24. Yeun JY, Kaysen GA: Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997; 30:923-927.
25. Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25: 107-114.
26. Park YK, Kim JH, Seo AR, Kang EH, Kim SB, Park SK, Park JS: A cross-sectional study comparing the nutritional status of peritoneal dialysis and hemodialysis patients in Korea. J Ren Nutr 1999;9:149-156.
27. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
28. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995;47:573-578.
29. Bernstein LH, Leukhardt-Fairfield CJ, Pleban W, Rudolph R: Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support. Clin Chem 1989;35:271-274.
30. Erstad BL, Campbell DJ, Rollins CJ, Rappaport WD: Albumin and prealbumin concentrations in patients receiving postoperative parenteral nutrition. Pharmacotherapy 1994;4:458-462.
31. Docci D, Bilancioni R, Pistocchi E, Baldrati L, Capponcini C, Dclvecchio C, Feletti C: Evolution of serum prealbumin following hemodialysis: Effect of different dialysis membranes. Nephron 1992;62:145-149.
32. Clark MA, Hentzen BT, Plank LD, Hill GI: Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury. J Parenter Enteral Nutr 1996;20:363-370.
33. Kopple J, Shinaberger J, Coburn J, Sorensen M, Rubini M: Optimal dietary protein treatment during chronic hemodialysis. ASAIO Trans 1989;15:302-308.
34. Acchiardo SR, Moore LW, Latour AT: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983;24(suppl 16):S-199-S-203.
35. Phillips ME, Havard J, Howard JP: Oral essential amino supplementation in patients in maintenance hemodialysis. Clin Nephrol 1978; 9:241-248.
36. Hacking E, Kohler H, Zobel R, Lamellel E-M. Mader H, Opferkuch W, Prellwitz W, Keim HF, Muller D: Treatment with essential amino acids in patients on chronic hemodialysis: A double blind crossover study. Am J Clin Nutr 1987;31:1821-1826.
37. Compher C, Mullen J, Barker C: Nutritional support in renal failure. Surg Clin N Am 1991; 71:597-608.
38. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH: Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79:1635-1641.
39. 2-macroglobulin and reduced synthesis of albumin by cultured rat hepatocytes. J Immunol Meth 1985;76:317-327.
40. 2-macroglobulin synthesis in rat hepatocyte primary cultures. FEBS Lett 1985;190:271-274.
41. 1 acid glycoprotein gene transcription. J Biol Chem 1985;260:15386-15389.
42. Jamieson JC, Kaplan HA, Woloski BMNJ, Hellman M, Ham K: Glycoprotein biosynthesis during the acute-phase response to inflammation. Can J Biochem Cell Biol 1983;61: 1041-1048.
43. Koj A, Gauldie J, Regoecsi E, Sander DN, Sweeney GD: The acute-phase response of cultured rat hepatocytes. Biochem J 1984;224: 505-514.
44. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986;78:1349-1355.
45. 1 acid glycoprotein RNA during inflammation. J Biol Chem 1987;262:12826-12831.
46. Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, Power B, Hudson P, Schreiber B: Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem 1988;263:480-488.
47. Samadani U, Qian X, Costa RH: Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform. Gene Expr 1996;6:23-33.
48. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT: The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995;102:217-223.
49. Clark GH, Fraser CG: Biological variation of acute phase proteins. Ann Clin Biochem 1993; 30:373-376.
50. Milland J, Tsykin A, Thomas T, Aldred AR, Cole T, Schreiber G: Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990;259:G340-G347.
51. Guo-Fen T, De Jong F, Apostolopoulos J, Nagashima M, Fidge N, Schreiber G, Howlett G: Effect of acute inflammation on rat apolipoprotein mRNA levels. Inflammation 1987;11: 241-251.
52. Jensen LE, Whitehead AS: Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 1998;334:489-503.
53. King AJ, Kehayias JJ, Roubenoff R, Schmid CH, Pereira BJ: Cytokine production and nutritional status in hemodialysis patients. Int J Artif Organs 1998;21:4-11.
54. Pereira BJ, King AJ, Falagas ME, Dinarello CA: Interleukin-1 receptor antagonist: An index of dialysis-induced interleukin-1 production. Nephron 1994;67:358-361.
55. Higuchi T, Yamamoto C, Kuno T, Mizuno M, Takahashi S, Kanmatsuse K: Increased production of interleukin-1 beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure. Nephron 1997;76:26-31.
56. Sreedhara R, Avram MM, Blanco M, Batish R, Avram MM, Mittman N: Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 1996;28:937-942.
57. Koenig W, Sund M. Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;19:237-242.
58. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
59. Ridker PM, Cushman M, Stampfer MJ, Tracy RP. Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336: 973-979.
60. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999:106: 506-512.
61. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U. Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
62. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-985.
63. Suzuki K, Kuriyama M, Saito T, Ichinose A: Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5́-flanking region. J Clin Invest 1997;15:1361-1366.
64. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91:397-401.
65. Koda Y, Nishi S, Suzuki M, Hirasawa Y: Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients. Kidney Int 1999;71(suppl):S251-S231.
66. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M: Anti-inflammatory HDL becomes proinflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995;96: 2758-2767.
67. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998;12: 2368-2376.
68. Clevenger FW: Nutritional support in the patient with the systemic inflammatory response syndrome. Am J Surg 1993;165(2A suppl): 68S-74S.
69. Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25: 107-114.
70. Sun X, Martin V, Weiss RH, Kaysen GA: Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol 1993;264:F441-F447.
71. De Sain-van der Velden MG, Kayscn GA, de Meer K, Stellaard F, Voorbij HA, Reijngoud DJ, Rabelink TJ, Koomans HA: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 1998;53:181-188.
72. Stevenson FT, Greene S, Kaysen GA: Serum alpha-2-macroglobulin and alpha-1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms. Kidney Int 1998;53:67-75.
73. de Sain-van der Velden MG, Rabelink TJ, Reijngoud DJ, Gadellaa MM, Voorbij HA, Stellaard F, Kaysen GA: Plasma alpha-2-macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int 1998;54:530-535.
74. Weiss G: Iron and anemia of chronic disease. Kidney Int 1999;55:512-517.
75. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
76. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC: Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997;90:4979-4986.
77. Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB: Iron-responsive elements: Regulatory RNA sequences that control mRNA levels and translation. Science 1988;240:924-928.
78. Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
79. Ahluwalia N: Diagnostic utility of serum transferrin receptors measurement in assessing iron status. Nutr Rev 1998;56:133-141.
80. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD: Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992; 119:385-390.
81. Pettersson T, Kivivuori SM, Siimes MA: Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheumatol 1994;33:740-744.